Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Search Posts
Newsletter
Wall Street Meets the White House, EPA Rules on Greenhouse Gases and Health Care Divided
President Obama hosts a White House summit with Wall Street banking leaders The Environmental Protection Agency publishes its final rule designating greenhouse gases as a…
Newsletter
Climategate in Copenhagen, Antitrust for Health Care and Swine Flu Takes a Dive
The “Climategate” science scandal looms over global warming negotiations in Copenhagen, Denmark. Senators Patrick Leahy (D-VT) and Sheldon Whitehouse (D-RI) lobby to end the long-standing…
Citation
Big PhRMA Payoff: Hidden Tax on Pedialyte, Prenatal Vitamins, and Pain Relievers
Newsletter
Re-importing Drugs, TARP for Small Business and Palin on ClimateGate
The Senate health care debate stalls on the question of whether to permit the re-importation of drugs from countries with price controls. President Obama announces…
Study
Congressional Misdiagnosis
Why Repealing McCarran-Ferguson Will Harm Competition in Health Insurance Markets…
News Release
Stripping Insurers’ Antitrust Exemption is a Congressional Misdiagnosis, New Report Shows
Stripping Insurers’ Antitrust Exemption is a Congressional Misdiagnosis, New Report Shows McCarran-Ferguson Repeal Won’t Help Consumers, May Hurt Competition Washington, D.C., December 8,…